T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBI
1776
DELISTED
Hanesbrands
HBI
| $1.28M | ﹤0.01% |
124,233
+7,161
| +6% | +$89K |
|
1777
Navient
NAVI
$837M
| $1.28M | ﹤0.01% |
91,373
+657
| +0.7% | +$10.2K |
|
1778
Credit Acceptance
CACC
$6.09B
| $1.27M | ﹤0.01% |
2,690
-439
| -14% | -$242K |
|
1779
Primoris Services
PRIM
$4.48B
| $1.27M | ﹤0.01% |
58,441
+1,393
| +2% | +$33.5K |
|
1780
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
| $1.27M | ﹤0.01% |
20,944
| – | – |
|
|
PINC
1781
DELISTED
Premier
PINC
| $1.27M | ﹤0.01% |
35,627
+182
| +0.5% | +$6.66K |
|
1782
Coca-Cola Europacific Partners
CCEP
$47.4B
| $1.26M | ﹤0.01% |
24,444
+2,198
| +10% | +$113K |
|
|
XHR
1783
Xenia Hotels & Resorts
XHR
$1.77B
| $1.26M | ﹤0.01% |
86,879
-21,740
| -20% | -$387K |
|
|
B
1784
Barrick Mining
B
$68.2B
| $1.26M | ﹤0.01% |
71,347
+11,300
| +19% | +$245K |
|
1785
LXP Industrial Trust
LXP
$3.57B
| $1.25M | ﹤0.01% |
23,191
+409
| +2% | +$24.6K |
|
1786
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $1.24M | ﹤0.01% |
6,013
| – | – |
|
|
UCB
1787
United Community Banks
UCB
$4.44B
| $1.24M | ﹤0.01% |
41,114
+818
| +2% | +$25.2K |
|
1788
First Merchants
FRME
$2.75B
| $1.23M | ﹤0.01% |
34,429
+628
| +2% | +$24.7K |
|
1789
TTEC Holdings
TTEC
$79.9M
| $1.22M | ﹤0.01% |
18,010
+590
| +3% | +$41.4K |
|
1790
COPT Defense Properties
CDP
$4.22B
| $1.22M | ﹤0.01% |
46,610
+636
| +1% | +$17.2K |
|
1791
MillerKnoll
MLKN
$1.6B
| $1.22M | ﹤0.01% |
46,484
+606
| +1% | +$18.4K |
|
1792
Stoneridge
SRI
$203M
| $1.22M | ﹤0.01% |
70,958
+5,666
| +9% | +$108K |
|
1793
La-Z-Boy
LZB
$1.67B
| $1.22M | ﹤0.01% |
51,292
+860
| +2% | +$22.1K |
|
|
AYX
1794
DELISTED
Alteryx Inc
AYX
| $1.21M | ﹤0.01% |
24,989
+5,833
| +30% | +$349K |
|
|
WWE
1795
DELISTED
World Wrestling Entertainment
WWE
| $1.21M | ﹤0.01% |
19,325
-637
| -3% | -$39.4K |
|
1796
CareTrust REIT
CTRE
$9.24B
| $1.21M | ﹤0.01% |
65,425
+3,782
| +6% | +$67.1K |
|
1797
Outfront Media
OUT
$5.31B
| $1.2M | ﹤0.01% |
72,103
+15,113
| +27% | +$329K |
|
|
WLL
1798
DELISTED
Whiting Petroleum Corporation
WLL
| $1.2M | ﹤0.01% |
17,655
+5,774
| +49% | +$466K |
|
1799
Stride
LRN
$3.47B
| $1.2M | ﹤0.01% |
29,406
-2,065
| -7% | -$76.5K |
|
1800
Kosmos Energy
KOS
$1.53B
| $1.2M | ﹤0.01% |
193,281
-12,919
| -6% | -$93.2K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.